Changes in Rous sarcoma virus RNA secondary structure near the primer binding site upon tRNA(Trp) primer annealing

Journal of Virology

Volumn 73, Issue 8, 1999, Pages 6307-6318

  Morris, Shannon ^a   Leis, Jonathan ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEASE; PRIMER RNA; TRYPTOPHAN TRANSFER RNA; VIRUS RNA;

ARTICLE; BINDING SITE; CONFORMATIONAL TRANSITION; DNA INTEGRATION; DNA PACKAGING; DNA TEMPLATE; NONHUMAN; PEPTIDE MAPPING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; RNA BINDING; RNA SEQUENCE; RNA STRUCTURE; ROUS SARCOMA ONCOVIRUS; VIRUS MUTANT; VIRUS REPLICATION;

EID: 0032769389     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.8.6307-6318.1999     Document Type: Article

References (34)

1. Aiyar, A., D. Cobrinik, Z. Ge, H. J. Kung, and J. Leis. 1992. Interaction between retroviral U5 RNA and the T psi C loop of the tRNA(Trp) primer is required for efficient initiation of reverse transcription. J. Virol, 66:2464-2472.
2. Aiyar, A., and J. Leis. 1994. Unpublished data.
3. Arts, E. J., S. R. Stetor, X. Li, J. W. Rausch, K. J. Howard, B. Ehresmann, T. W. North, B. M. Wohrl, R. S. Goody, M. A. Wainberg, and S. F. Grice. 1996. Initiation of (-) strand DNA synthesis from tRNA(3Lys) on lentiviral RNAs: implications of specific HIV-1 RNA-tRNA(3Lys) interactions inhibiting primer utilization by retroviral reverse transcriptases. Proc. Natl. Acad. Sci. USA 93:10063-10068.
4. Auron, P. E., L. D. Weber, and A. Rich. 1982. Comparison of transfer ribonucleic acid structures using cobra venom and S1 endonucleases. Biochemistry 21:4700-4706.
5. Baudin, F., R. Marquet, C. Isel, J. L. Darlix, B. Ehresmann, and C. Ehresmann. 1993. Functional sites in the 5′ region of human immunodeficiency virus type 1 RNA form defined structural domains. J. Mol. Biol. 229:382-397.
6. Chan, B., and K. Musier-Forsyth. 1997. The nucleocapsid protein specifically anneals tRNALys-3 onto a noncomplementary primer binding site within the HIV-1 RNA genome in vitro. Proc. Natl. Acad. Sci. USA 94: 13530-13535.
7. Cobrinik, D., A. Aiyar, Z. Ge, M. Katzman, H. Huang, and J. Leis. 1991. Overlapping retrovirus U5 sequence elements are required for efficient integration and initiation of reverse transcription. J. Virol. 65:3864-3872.
8. Cobrinik, D., L. Soskey, and J. Leis. 1988. A retroviral RNA secondary structure required for efficient initiation of reverse transcription. J. Virol. 62:3622-3630.
9. De Rocquigny, H., C. Gabus, A. Vincent, M. C. Fournie-Zaluski, B. Roques, and J. L. Darlix. 1992. Viral RNA annealing activities of human immunodeficiency virus type 1 nucleocapsid protein require only peptide domains outside the zinc fingers. Proc. Natl. Acad. Sci. USA 89:6472-6476.
10. Derrick, W. B., and J. Horowitz. 1993. Probing structural differences between native and in vitro transcribed Escherichia coli valine transfer RNA: evidence for stable base modification-dependent conformers. Nucleic Acids Res. 21: 4948-4953.
11. Donis-Keller, H., A. M. Maxam, and W. Gilbert. 1977. Mapping adenines, guanines, and pyrimidines in RNA. Nucleic Acids Res. 4:2527-2538.
12. Elgavish, T., M. S. VanLoock, and S. C. Harvey. 1999. Exploring three-dimensional structures of the HIV-1 RNA/tRNALys3 initiation complex. J. Mol. Biol. 285:449-453.
13. Favorova, O. O., F. Fasiolo, G. Keith, S. K. Vassilenko, and J. P. Ebel. 1981. Partial digestion of tRNA-aminoacyl-tRNA synthetase complexes with cobra venom ribonuclease. Biochemistry 20:1006-1011.
14. Fosse, P., M. Mouge, K. Gerard, E. Westhof, B. Ehresmann, and C. Ehresmann. 1998. Modified nucleotides of tRNAPro restrict interactions in the binary primer/template complex of M-MuLV. J. Mol. Biol. 275:731-746.
15. Garret, M., P. Romby, R. Giege, and S. Litvak. 1984. Interactions between avian myeloblastosis reverse transcriptase and tRNATrp. Mapping of complexed tRNA with chemicals and nucleases. Nucleic Acids Res. 12:2259-2271.
16. Garrett, R. A., and S. O. Olesen. 1982. Structure of eukaryotic 5S ribonucleic acid: a study of Saccharomyces cerevisiae 5S ribonucleic acid with ribonucleases. Biochemistry 21:4823-4830.
17. Isel, C., C. Ehresmann, G. Keith, B. Ehresmann, and R. Marquet 1995. Initiation of reverse transcription of HIV-1: secondary structure of the HIV-1 RNA/tRNA(3Lys) (template/primer). J. Mol. Biol. 247:236-250.
18. Isel, C., J. M. Lanchy, S. F. Le Grice, C. Ehresmann, B. Ehresmann, and R. Marquet. 1996. Specific initiation and switch to elongation of human immunodeficiency virus type 1 reverse transcription require the post-transcriptional modifications of primer tRNA3Lys. EMBO J. 15:917-924.
19. Isel, C., R. Marquet, G. Keith, C. Ehresmann, and B. Ehresmann. 1993. Modified nucleotides of tRNA(3Lys) modulate primer/template loop-loop interaction in the initiation complex of HIV-1 reverse transcription. J. Biol. Chem. 268:25269-25272.
20. Isel, C., E. Westhof, C. Massire, S. F. Le Grice, B. Ehresmann, C. Ehresmann, and R. Marquet 1999. Structural basis for the specificity of the initiation of HIV-1 reverse transcription. EMBO J. 18:1038-1048.
21. Kang, S. M., Z. Zhang, and C. D. Morrow. 1997. Identification of a sequence within U5 required for human immunodeficiency virus type 1 to stably maintain a primer binding site complementary to tRNA(Met). J. Virol. 71:207-217.
22. Li, X., Y. Quan, E. J. Arts, Z. Li, B. D. Preston, H. de Rocquigny, B. P. Roques, J. L. Darlix, L. Kleiman, M. A. Parniak, and M. A. Wainberg. 1996. Human immunodeficiency virus type 1 nucleocapsid protein (NCp7) directs specific initiation of minus-strand DNA synthesis primed by human tRNA(Lys3) in vitro: studies of viral RNA molecules mutated in regions that flank the primer binding site. J. Virol. 70:4996-5004.
23. Liang, C., X. Li, L. Rong, P. Inouye, Y. Quan, L. Kleiman, and M. A. Wainberg. 1997. The importance of the A-rich loop in human immunodeficiency virus type 1 reverse transcription and infectivity. J. Virol. 71:5750-5757.
24. Lin, J. H., and H. L. Levin. 1998. Reverse transcription of a self-primed retrotransposon requires an RNA structure similar to the U5-IR stem-loop of retroviruses. Mol. Cell. Biol. 18:6859-6869.
25. Lockard, R. E., and A. Kumar. 1981. Mapping tRNA structure in solution using double-strand-specific ribonuclease V1 from cobra venom. Nucleic Acids Res. 9:5125-5140.
26. Lowman, H. B., and D. E. Draper. 1986. On the recognition of helical RNA by cobra venom V1 nuclease. J. Biol. Chem. 261:5396-5403.
27. Miller, J. T., Z. Ge, S. Morris, K. Das, and J. Leis. 1997. Multiple biological roles associated with the Rous sarcoma virus 5′ untranslated RNA U5-IR stem and loop. J. Virol. 71:7648-7656.
28. Prats, A. C., L. Sarih, C. Gabus, S. Litvak, G. Keith, and J. L. Darlix. 1988. Small finger protein of avian and murine retroviruses has nucleic acid annealing activity and positions the replication primer tRNA onto genomic RNA. EMBO J. 7:1777-1783.
29. Schimmel, P. R., D. Söll, and N. Abelson (ed.). 1979. Transfer RNA: structure, properties, and recognition. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
30. Serra, M. J., and D. H. Turner. 1995. Predicting thermodynamic properties of RNA. Methods Enzymol. 259:242-261.
31. Skripkin, E., C. Isel, R. Marquet, B. Ehresmann, and C. Ehresmann. 1996. Psoralen crosslinking between human immunodeficiency virus type 1 RNA and primer tRNA3(Lys). Nucleic Acids Res. 24:509-514.
32. Vournakis. J. N., J. Celantano, M. Finn, R. E. Lockard, T. Mitra, G. Pavlakis, A. Troutt, M. van den Berg, and R. M. Wurst. 1981. Sequence and structure analysis of end-labeled RNA with nucleases. Gene Amplif. Anal. 2:267-298.
33. Wakefield, J. K., S. M. Kang, and C. D. Morrow. 1996. Construction of a type 1 human immunodeficiency virus that maintains a primer binding site complementary to tRNA(His). J. Virol. 70:966-975.
34. Waters, L. C., W. K. Yang, B. C. Mullin, and J. L. Nichols. 1975. Purification of tryptophan transfer RNA from chick cells and its identity with "spot 1" RNA of Rous sarcoma virus. J. Biol. Chem. 250:6627-6629.